QC2 offers the following GCP and GLP bioanalytical laboratory audits:
Large and Small Molecules
Audits of bioanalytical laboratories, a unique specialty of QC2, are conducted to assess systems and facilities for compliance with 21 CFR Part 11, 58, and 320, Standard Operating Procedures, and the International Conference on Harmonisation M10 Guideline: Bioanalytical Method Validation and Study Sample Analysis (May 2022).
Biomarkers
Biomarker discovery and detection are typically conducted at esoteric testing laboratories and do not fall under any specific guidances or regulations. QC2 will assess systems and facilities for compliance with applicable aspects of the International Conference on Harmonisation M10 Guideline: Bioanalytical Method Validation and Study Sample Analysis (May 2022), 21 CFR Part 11, as well as facility Standard Operating Procedures.
